Evaluation of Alpha Interferon/Isotretinoin or Alpha Interferon/All Trans Retinoic Acid in Cervical Cancer, Phase II

Closed

Phase

Accrual

100%

Published

Abbreviated Title

Evaluation of Alpha Interferon/Isotretinoin or Alpha Interferon/All Trans Retinoic Acid in Cervical Cancer, Phase II

Activated

09/15/1992

Closed

05/15/1996

Research committees

Gynecologic Cancer

Publication Information Expand/Collapse

1998

13-cis-retinoic acid or all-trans-retinoic acid plus interferon-a in recurrent cervical cancer: A Southwest Oncology Group phase II randomized trial.

GR Weiss;PY Liu;DS Alberts;Y Peng;E Fisher;MJ Xu;SA Scudder;LH Baker;DF Moore Jr;SM Lippman Gynecologic Oncology 71:386-390

1997

A randomized phase II trial of 13-cis-retinoic acid (CRA) or all-trans-retinoic acid (ATRA) plus interferon alpha 2a (IFN) for metastatic or recurrent squamous/adenosquamous carcinoma of the uterine cervix: a Southwest Oncology Group study

GR Weiss;PY Liu;DS Alberts;DR Gandara;LH Baker;HE Hynes Proc of the American Society of Clinical Oncology 16:355a(#1268)